Literature DB >> 24570914

Chemoprevention and novel therapy for hepatocellular carcinoma associated with chronic hepatitis B virus infection.

Ih-Jen Su1, Wen-Chuan Hsieh1, Hung-Wen Tsai2, Han-Chieh Wu1.   

Abstract

Entities:  

Year:  2013        PMID： 24570914      PMCID： PMC3924635          DOI： 10.3978/j.issn.2304-3881.2012.10.08

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

1.  Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence.

Authors:  Giorgio Ercolani; Gian Luca Grazi; Matteo Ravaioli; Massimo Del Gaudio; Andrea Gardini; Matteo Cescon; Giovanni Varotti; Francesco Cetta; Antonino Cavallari
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

Review 2.  Aspirin in the chemoprevention of colorectal neoplasia: an overview.

Authors:  Andrew T Chan; Nadir Arber; John Burn; Whay Kuang Chia; Peter Elwood; Mark A Hull; Richard F Logan; Peter M Rothwell; Karsten Schrör; John A Baron
Journal:  Cancer Prev Res (Phila)       Date:  2011-11-14

Review 3.  Does antiviral therapy prevent hepatocellular carcinoma?

Authors:  Hellan Kwon; Anna S Lok
Journal:  Antivir Ther       Date:  2011

4.  Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice.

Authors:  F V Chisari; K Klopchin; T Moriyama; C Pasquinelli; H A Dunsford; S Sell; C A Pinkert; R L Brinster; R D Palmiter
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

5.  Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.

Authors:  Giovanni Sitia; Roberto Aiolfi; Pietro Di Lucia; Marta Mainetti; Amleto Fiocchi; Francesca Mingozzi; Antonio Esposito; Zaverio M Ruggeri; Francis V Chisari; Matteo Iannacone; Luca G Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

6.  Viral hepatitis and fatty liver disease: how an unwelcome guest makes pâté of the host.

Authors:  Andrew J Brown
Journal:  Biochem J       Date:  2008-12-01       Impact factor: 3.857

Review 7.  Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link.

Authors:  Abby B Siegel; Andrew X Zhu
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

Review 8.  Hepatitis B virus immunopathogenesis.

Authors:  F V Chisari; C Ferrari
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

9.  HCC heterogeneity: molecular pathogenesis and clinical implications.

Authors:  Emilia Fransvea; Angelo Paradiso; Salvatore Antonaci; Gianluigi Giannelli
Journal:  Cell Oncol       Date:  2009       Impact factor: 6.730

10.  Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.

Authors:  Yujin Hoshida; Sebastian M B Nijman; Masahiro Kobayashi; Jennifer A Chan; Jean-Philippe Brunet; Derek Y Chiang; Augusto Villanueva; Philippa Newell; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Stacey Gabriel; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  Cancer Res       Date:  2009-09-01       Impact factor: 12.701
View more
  7 in total

1.  Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study.

Authors:  Pin-Gao Yan; Ruo-Yu Wang; Jin Zhang; Wen-Ming Cong; Hui Dong; Hong-Yu Yu; Wan Yee Lau; Meng-Chao Wu; Wei-Ping Zhou
Journal:  J Gastrointest Surg       Date:  2018-01-08       Impact factor: 3.452

Review 2.  Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Chiao-Fang Teng; Han-Chieh Wu; Woei-Cherng Shyu; Long-Bin Jeng; Ih-Jen Su
Journal:  Cell Transplant       Date:  2017-02-14       Impact factor: 4.064

Review 3.  Hepatocellular carcinoma and hepatitis B surface protein.

Authors:  Yong-Wei Li; Feng-Cai Yang; Hui-Qiong Lu; Jiong-Shan Zhang
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

4.  Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis.

Authors:  Chiao-Fang Teng; Han-Chieh Wu; Wen-Chuan Hsieh; Hung-Wen Tsai; Ih-Jen Su
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

5.  Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade.

Authors:  Chiao-Fang Teng; Wen-Chuan Hsieh; Han-Chieh Wu; Yih-Jyh Lin; Hung-Wen Tsai; Wenya Huang; Ih-Jen Su
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

Review 6.  The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis.

Authors:  Ih-Jen Su; Lily Hui-Ching Wang; Wen-Chuan Hsieh; Han-Chieh Wu; Chiao-Fang Teng; Hung-Wen Tsai; Wenya Huang
Journal:  J Biomed Sci       Date:  2014-10-15       Impact factor: 8.410

Review 7.  HBV-Induced Immune Imbalance in the Development of HCC.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.